🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10293+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10293 recruiting trials

Phase 1RecruitingNCT06922604

Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma

👨‍⚕️ James Godfrey, City of Hope Medical Center📍 1 site📅 Started Jul 2025View details ↗
Phase 1RecruitingNCT07054684

Study of BHV-1400 in IgA Nephropathy

🏥 Biohaven Therapeutics Ltd.📍 12 sites📅 Started Jul 2025View details ↗
Phase 1, PHASE2RecruitingNCT06721013

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

👨‍⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 45 sites📅 Started Jul 2025View details ↗
Phase 1RecruitingNCT06917885

CUE-102 in Recurrent Glioblastoma

👨‍⚕️ David Reardon, MD, Dana-Farber Cancer Institute📍 2 sites📅 Started Jul 2025View details ↗
Phase 2RecruitingNCT07209059

PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma

👨‍⚕️ Evgeny E Zvonkov, MD, PhD, National Medical Research Center for Hematology📍 1 site📅 Started Jul 2025View details ↗
NARecruitingNCT07021495

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

👨‍⚕️ Robert Rissmann, Professor📍 8 sites📅 Started Jul 2025View details ↗
Phase 2, PHASE3RecruitingNCT06328608

A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease

🏥 Chiesi Farmaceutici S.p.A.📍 12 sites📅 Started Jul 2025View details ↗
Phase 1RecruitingNCT07361029

CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia

🏥 King Faisal Specialist Hospital & Research Center📍 1 site📅 Started Jul 2025View details ↗
Phase 2RecruitingNCT06962787

A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer

🏥 Sichuan Baili Pharmaceutical Co., Ltd.📍 1 site📅 Started Jul 2025View details ↗
Phase 3RecruitingNCT07080905

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

👨‍⚕️ Study Director, CSL Behring📍 8 sites📅 Started Jul 2025View details ↗
RecruitingNCT07078136

Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis

🏥 Huazhong University of Science and Technology📍 1 site📅 Started Jul 2025View details ↗
NAEnrolling by InvitationNCT07122323

Robotic Arm-assisted THA Vs. Conventional THA in Legg-Calvé-Perthes Disease

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Jul 2025View details ↗
Phase 3RecruitingNCT06858319

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 6 sites📅 Started Jul 2025View details ↗
Phase 1RecruitingNCT07089641

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

👨‍⚕️ Phioanh Nghiemphu, MD, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Jul 2025View details ↗
RecruitingNCT07120724

Real-World Study on Chinese Medicine for Treating Chikungunya Fever

🏥 Guangzhou University of Traditional Chinese Medicine📍 1 site📅 Started Jul 2025View details ↗
RecruitingNCT07354295

Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer (Radiogenomics-Esophagus)

🏥 Shu Peng📍 1 site📅 Started Jul 2025View details ↗
NARecruitingNCT07056673

Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study

👨‍⚕️ Lin Tao, MM, Shenyang Medical College📍 1 site📅 Started Jul 2025View details ↗
Phase 3RecruitingNCT07146022

Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

👨‍⚕️ Reid Waldman, M.D., Veradermics, Inc.📍 71 sites📅 Started Jul 2025View details ↗
RecruitingNCT07339826

Overview of Knowledge and Practices Among Healthcare Professionals Treating Eating Disorders

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started Jul 2025View details ↗
Phase 2RecruitingNCT06859424

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

🏥 Center for International Blood and Marrow Transplant Research📍 13 sites📅 Started Jul 2025View details ↗
← PreviousPage 83 of 515Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →